Received Apr 23, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| TDAP | TDAP (BOOSTRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | FY293 | IM / LA |
Patient receive dose on 4/21/2026 which too early based on previous dose in 2025, next dose should be in 2035 . she experienced no adverse event